Psychedelic Microdosing, Mindfulness, and Anxiety: A Cross-Sectional Mediation Study
Journal of Psychoactive Drugs June 12, 2022 Vincent Hartong, Arnold van Emmerik 11 citations
People who microdose psychedelics, either currently or in the past, report lower trait anxiety than those who have never microdosed. This association appears to be partly explained by higher trait mindfulness, particularly the facets of non-judging and non-reactivity. However, when participants who had previously taken a full psychedelic dose were excluded from the analysis, the link between microdosing and lower anxiety disappeared. The findings indicate that previous macrodose experience may account for the observed differences, and randomized controlled trials are needed to test whether microdosing itself reduces anxiety.